
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
The Michael J. Fox Foundation for Parkinson's Research and 23andMe have launched the Fox Insight Data Exploration Network. Fox DEN contains patient-reported outcomes, de-identified genetic data and data exploration tools from the largest cohort in Parkinson's disease research. The network features information from surveys on health and disease, symptoms, daily activities, and other factors relevant to Parkinson's coupled with genetic information from 23andMe customers who have joined the Fox Insight study.
For more information, click






